Baylor University Medical Center issued the following announcement.
Baylor Scott & White Research Institute today announces a new research project with Newsight Imaging to evaluate the efficacy of a potential new COVID-19 screening solution
The research project will include the evaluation of Israeli startup Newsight Imaging’s SpectraLIT™ – a portable spectral analysis device powered by machine learning and artificial intelligence. The device is licensed to Newsight’s joint venture with Sheba Medical Center, Virusight Diagnostic
The project is the latest effort for Baylor Scott & White, which through Baylor Scott & White Research Institute continues to mobilize staff and resources, including components needed to integrate critical patient-safety measures at every participating site within the Baylor Scott & White system. Baylor Scott & White Research Institute’s COVID-19 therapeutic task force and four institutional review boards have now approved more than 30 COVID-19 research initiatives: industry sponsored drug trials, investigator-initiated drug trials and research studies, as well as observational and data studies designed to help increase knowledge around case trends, viral epidemiology, and care best practices.
“We are optimistic about our laboratory’s ability to continue contributing to the advancement of innovative, cost-effective, accurate methods of detecting SARS-CoV-2,” said Sheila Dobin, PhD, principal investigator of the research project at Baylor Scott & White Medical Center - Temple. “Since the beginning of the virus’ impact on our nation, we have been working to help address soaring demand for tests and helping to produce accurate results quickly.
Eyal Yatskan, co-founder and CTO of Newsight added: "We are delighted to work together with Baylor Scott & White, and we are looking forward to successfully completing the analytical and clinical evaluations. Our unique spectral technology, which is based on years of extensive efforts, is the right solution, just in time, to provide a mass screening solution for the return to normal life. We are glad to get the opportunity to show and prove the validity of our solution to such a respectable institution such as Baylor Scott & White."
Newsight Imaging’s SpectraLIT™ method has been proven in a pre-clinical study at Sheba Medical Center, the largest hospital in Israel and the Middle East, to identify viruses in seconds.
Original source can be found here.
Alerts Sign-up